|
1
|
Coleman RE: Metastatic bone disease:
Clinical features, pathophysiology and treatment strategies. Cancer
Treat Rev. 27:165–176. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hamaoka T, Madewell JE, Podoloff DA,
Hortobagyi GN and Ueno NT: Bone imaging in metastatic breast
cancer. J Clin Oncol. 22:2942–2953. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kozlow W and Guise TA: Breast cancer
metastasis to bone: Mechanisms of osteolysis and implications for
therapy. J Mammary Gland Biol Neoplasia. 10:169–180. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kingsley LA, Fournier PG, Chirgwin JM and
Guise TA: Molecular biology of bone metastasis. Mol Cancer Ther.
6:2609–2617. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li M, Amizuka N, Takeuchi K, Freitas PH,
Kawano Y, Hoshino M, Oda K, Nozawa-Inoue K and Maeda T:
Histochemical evidence of osteoclastic degradation of extracellular
matrix in osteolytic metastasis originating from human lung small
carcinoma (SBC-5) cells. Microsc Res Tech. 69:73–83. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li M, Sasaki T, Ono K, de Freitas PH,
Sobhan U, Kojima T, Shimomura J, Oda K and Amizuka N: Distribution
of macrophages, osteoclasts and the B-lymphocyte lineage in
osteolytic metastasis of mouse mammary carcinoma. Biomed Res.
28:127–137. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jacob K, Webber M, Benayahu D and Kleinman
HK: Osteonectin promotes prostate cancer cell migration and
invasion: A possible mechanism for metastasis to bone. Cancer Res.
59:4453–4457. 1999.PubMed/NCBI
|
|
8
|
Lynch CC and Matrisian LM: Matrix
metalloproteinases in tumor-host cell communication.
Differentiation. 70:561–573. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nannuru KC, Futakuchi M, Varney ML,
Vincent TM, Marcusson EG and Singh RK: Matrix metalloproteinase
(MMP)-13 regulates mammary tumor-induced osteolysis by activating
MMP9 and transforming growth factor-beta signaling at the
tumor-bone interface. Cancer Res. 70:3494–3504. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Scherer RL, Mclntyre JO and Matrisian LM:
Imaging matrix metalloproteinases in cancer. Cancer Metastasis Rev.
27:679–690. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee J, Weber M, Mejia S, Bone E, Watson P
and Orr W: A matrix metalloproteinase inhibitor, batimastat,
retards the development of osteolytic bone metastases by MDA-MB-231
human breast cancer cells in Balb C nu/nu mice. Eur J Cancer.
37:106–113. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weber MH, Lee J and Orr FW: The effect of
Neovastat (AE-941) on an experimental metastatic bone tumor model.
Int J Oncol. 20:299–303. 2002.PubMed/NCBI
|
|
14
|
Monteiro-Amado F, Castro-Silva II, Lima
CJ, Soares FA, Kowalski LP and Granjeiro JM: Immunohistochemical
evaluation of MMP-2, MMP-9 and CD31/microvascular density in
squamous cell carcinomas of the floor of the mouth. Braz Dent J.
24:3–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ohshiba T, Miyaura C, Inada M and Ito A:
Role of RANKL-induced osteoclast formation and MMP-dependent matrix
degradation in bone destruction by breast cancer metastasis. Br J
Cancer. 88:1318–1326. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morrison C, Mancini S, Cipollone J,
Kappelhoff R, Roskelley C and Overall C: Microarray and proteomic
analysis of breast cancer cell and osteoblast co-cultures: Role of
osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis. J
Biol Chem. 286:34271–34285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lafleur MA, Drew AF, de Sousa EL, Blick T,
Bills M, Walker EC, Williams ED, Waltham M and Thompson EW:
Upregulation of matrix metalloproteinases (MMPs) in breast cancer
xenografts: A major induction of stromal MMP-13. Int J Cancer.
114:544–554. 2005. View Article : Google Scholar
|
|
18
|
Huang S, Van Arsdall M, Tedjarati S,
McCarty M, Wu W, Langley R and Fidler IJ: Contributions of stromal
metalloproteinase-9 to angiogenesis and growth of human ovarian
carcinoma in mice. J Natl Cancer Inst. 94:1134–1142. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Björklund M and Koivunen E:
Gelatinase-mediated migration and invasion of cancer cells. Biochim
Biophys Acta. 1755:37–69. 2005.PubMed/NCBI
|
|
20
|
Li M, Hasegawa T, Hogo H, Tatsumi S, Liu
Z, Guo Y, Sasaki M, Tabata C, Yamamoto T, Ikeda K and Amizuka N:
Histological examination on osteoblastic activities in the alveolar
bone of transgenic mice with induced ablation of osteocytes. Histol
Histopathol. 28:327–335. 2013.PubMed/NCBI
|
|
21
|
Tsunoda M and Sharma RP: Modulation of
tumor necrosis factor alpha expression in mouse brain after
exposure to aluminum in drinking water. Arch Toxicol. 73:419–426.
1999. View Article : Google Scholar
|
|
22
|
Sasaki E, Tsunoda N, Hatanaka Y, Mori N,
Iwata H and Yatabe Y: Breast-specific expression of
MGB1/mammaglobin: An examination of 480 tumors from various organs
and clinicopathological analysis of MGB1-positive breast cancers.
Mod Pathol. 20:208–214. 2007. View Article : Google Scholar
|
|
23
|
Slattery ML, John E, Torres-Mejia G, Stern
M, Lundgreen A, Hines L, Giuliano A, Baumgartner K, Herrick J and
Wolff RK: Matrix metalloproteinase genes are associated with breast
cancer risk and survival: The Breast Cancer Health Disparities
Study. PLoS One. 8:e631652013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McCawley LJ and Matrisian LM: Matrix
metalloproteinases: They're not just for matrix anymore! Curr Opin
Cell Biol. 13:534–540. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nutter F, Holen I, Brown HK, Cross SS,
Evans CA, Walker M, Coleman RE, Westbrook JA, Selby PJ, Brown JE
and Ottewell PD: Different molecular profiles are associated with
breast cancer cell homing compared with colonisation of bone:
Evidence using a novel bone-seeking cell line. Endocr Relat Cancer.
21:327–341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yin JJ, Selander K, Chirgwin JM, Dallas M,
Grubbs BG, Wieser R, Massagué J, Mundy GR and Guise TA: TGF-beta
signaling blockade inhibits PTHrP secretion by breast cancer cells
and bone metastases development. J Clin Invest. 103:197–206. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Woodward JK, Holen I, Coleman RE and
Buttle DJ: The roles of proteolytic enzymes in the development of
tumour-induced bone disease in breast and prostate cancer. Bone.
41:912–927. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Balbín M, Pendás AM, Uría JA, Jiménez MG,
Freije JP and López-Otín C: Expression and regulation of
collagenase-3 (MMP-13) in human malignant tumors. APMIS. 107:45–53.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ni X, Xia T, Zhao Y, Zhou W, Wu N, Liu X,
Ding Q, Zha X, Sha J and Wang S: Downregulation of miR-106b induced
breast cancer cell invasion and motility in association with
overexpression of matrix metalloproteinase 2. Cancer Sci.
105:18–25. 2014. View Article : Google Scholar
|
|
30
|
Mastro AM, Gay CV, Welch DR, Donahue HJ,
Jewell J, Mercer R, DiGirolamo D, Chislock EM and Guttridge K:
Breast cancer cells induce osteoblast apoptosis: A possible
contributor to bone degradation. J Cell Biochem. 91:265–276. 2004.
View Article : Google Scholar : PubMed/NCBI
|
